Skip to content
Clinical Trials – home
The NetherlandsBack to the Netherlands

Clinical trials in Heerenveen

13 clinical trials in Heerenveen, The Netherlands across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

The NetherlandsOur site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)
Heerenveen at a glance
13
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

13 trials in Heerenveen

Open in trial search
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Sponsor:Eli Lilly & Co.
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Cabozantinib
  • Sponsor:Leids Universitair Medisch Centrum (LUMC)
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years
  • Substances:Follitropin Alfa
  • Sponsor:Amsterdam UMC Stichting
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Daratumumab
  • Sponsor:Haemato Oncology Foundation For Adults Netherlands
Countries:The NetherlandsThe Netherlands
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Amoxicillin Sodium
  • Sponsor:Universitair Medisch Centrum Utrecht
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Etripamil
  • Sponsor:Milestone Pharmaceuticals Inc.

Chronic lymphocytic leukaemia+2

Not yet recruiting
Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Venetoclax
  • Sponsor:Haemato Oncology Foundation For Adults Netherlands
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Fluorouracil
  • Sponsor:Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

Gestational diabetes

Not recruiting
Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:0–17 years · 18–64 years
  • Substances:Metformin Hydrochloride
  • Sponsor:Bethesda Diabetes Research Center B.V.

Myopia

Not recruiting
Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:0–17 years
  • Substances:Atropine Sulfate
  • Sponsor:Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:BOOG Study Center B.V.
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:BOOG Study Center B.V.

Other cities in the Netherlands

The busiest research cities in the country

All 103 cities in the Netherlands

Clinical research in Heerenveen

What the registry says about research in the country

01 Diabetes & Pregnancy Research

Investigating new approaches for gestational diabetes mellitus management, focusing on medication-based interventions to improve maternal and child health outcomes during pregnancy and postpartum periods.

  • Maternal Health
  • Pregnancy Complications
  • Long-term Outcomes

Studies extend from pregnancy through postpartum, evaluating treatment effectiveness over multiple years.

02 Oncology Studies

Comprehensive research into breast cancer and multiple myeloma treatments, exploring innovative therapeutic approaches and treatment optimization strategies.

  • HER2-Positive Breast Cancer
  • Hormone Receptor Positive Cancer
  • Multiple Myeloma Management

Evaluating targeted therapies and treatment schedules to enhance patient outcomes.

03 Specialized Medicine

Focused investigations in myopia treatment and pancreatic cancer management, comparing different therapeutic approaches for optimal patient care.

  • Progressive Myopia Control
  • Pancreatic Cancer Treatment
  • Neoadjuvant Therapy

Studies aim to establish more effective treatment protocols and improve quality of life outcomes.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).